A New Look at Precipitants of Overt Hepatic Encephalopathy in Cirrhosis

Dig Dis Sci. 2017 Aug;62(8):2166-2173. doi: 10.1007/s10620-017-4630-y. Epub 2017 May 30.

Abstract

Background and aims: Overt hepatic encephalopathy (HE) is a major cause of significant morbidity and mortality in patients with liver cirrhosis. We examined the frequency and profile of the precipitating factors resulting in hospitalizations for overt HE.

Methods: We conducted both retrospective and prospective studies to identify clinical precipitants of overt HE in patients with cirrhosis. The retrospective study patients were hospitalized at a large urban safety-net hospital, and the prospective study included the patients admitted at a liver transplant center.

Results: There were a total of 149 patients with cirrhosis and overt HE (91 males, mean age 55.3 ± 8.6 years) in the retrospective group and 45 patients (27 males, mean age 58.3 ± 8.2 years) in the prospective group of the study. The average MELD score was 16 ± 6.8 in the retrospective group and 22.7 ± 7.2 in the prospective group. Dehydration (46-76%), acute kidney injury (32-76%), lactulose nonadherence (about 50%), constipation (about 40%), and infections (20-42%) were the most frequently identified precipitants for hospitalization in retrospective and prospective groups. Multiple precipitants were identified in 60 (40.3%) patients in the retrospective group and 34 (76%) patients in the prospective group.

Conclusions: Multiple concurrent precipitating factors were identified in the majority of patients with overt HE requiring hospitalization. Dehydration due to various causes was the most common precipitant of overt HE, followed by acute kidney injury (AKI), constipation, and infections. Prevention of dehydration, AKI, and constipation by close outpatient monitoring may be an effective measure to prevent hospitalization for overt HE in patients with cirrhosis.

Keywords: Cirrhosis; MELD score; Overt hepatic encephalopathy.

MeSH terms

  • Acute Kidney Injury / complications
  • Assessment of Medication Adherence
  • Constipation / complications
  • Dehydration / complications
  • Female
  • Gastrointestinal Agents / therapeutic use
  • Hepatic Encephalopathy / etiology*
  • Hospitalization / statistics & numerical data*
  • Humans
  • Lactulose / therapeutic use
  • Liver Cirrhosis / complications*
  • Liver Cirrhosis / drug therapy
  • Male
  • Middle Aged
  • Prospective Studies
  • Retrospective Studies
  • Safety-net Providers / statistics & numerical data
  • Severity of Illness Index

Substances

  • Gastrointestinal Agents
  • Lactulose